Answers are grounded in this paper and cite their sources.
Alzheimer's disease (AD) is a prevalent neurodegenerative disorder that seriously endangers the physical and mental health of the elderly population. Currently, the molecular pathogenic mechanism of this disease has not been fully elucidated, and there are limitations in clinical treatment methods, making it difficult to curb the progression of the disease at its root. This article systematically analyzed the interactive effects of the three core pathological mechanisms in AD, namely Aβ deposition, excessive phosphorylation of Tau protein, and neuroinflammation, and reviewed the advantages and disadvantages of traditional interventions, nano-delivery carriers, and nasal administration as new treatment technologies. The results show that the pathological process of AD is dominated by a multi-dimensional interactive network, and the APOE4 gene and chronic neuroinflammation play a key role in upstream regulation. Simply removing pathological proteins cannot stop disease progression, while targeted precise intervention such as p-tau217 and ceRNA regulatory networks show significant potential. This study clarified the multi-factor interwoven pathological regulatory mechanism of AD, complemented the cognitive limitations of single pathological research, and provided theoretical support for the development of early screening markers and precise targeted treatment. The causal relationship between neuroinflammation and pathological protein lesions is still unclear at present. Future research can focus on the pathological dynamic changes during the disease latency period, optimize multi-target combined treatment plans, improve nano-nasal administration technology, and promote the clinical translation and application of new treatment strategies.
No takes yet. Share an insight, caveat, or question.
Yingting He (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: